Identification of serum biomarkers for gastric cancer diagnosis using a human proteome microarray

Molecular and Cellular Proteomics

Volumn 15, Issue 2, 2016, Pages 614-623

  Yang, Lina ^a,b,c   Wang, Jingfang ^a   Li, Jianfang ^a   Zhang, Hainan ^a,b   Guo, Shujuan ^a,b   Yan, Min ^a   Zhu, Zhenggang ^a   Lan, Bin ^d   Ding, Youcheng ^e   Xu, Ming ^f   Li, Wei ^g   Gu, Xiaonian ^h   Qi, Chong ⁱ   Zhu, Heng ^j   Shao, Zhifeng ^b   Liu, Bingya ^a   Tao, Sheng Ce ^a,b  

^a Chinese National Human Genome Center at Shanghai   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d FUJIAN MEDICAL UNIVERSITY   (China)

^e Tongji University   (China)

^f Shanghai Jiao Tong University School of Medicine   (China)

^g Department of Medical Imaging   (China)

^h Pudong Gongli Hospital   (China)

ⁱ Urology Institute of Fudan University   (China)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; AUTOANTIBODY; BIOLOGICAL MARKER; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PROTEOME; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN MICROARRAY; STOMACH CANCER; BIOSYNTHESIS; BLOOD; EARLY CANCER DIAGNOSIS; GENETICS; PATHOLOGY; PROGNOSIS; STOMACH TUMOR;

BIOMARKERS, TUMOR; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; NEOPLASM PROTEINS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; PROTEOME; STOMACH NEOPLASMS;

EID: 84957916873     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M115.051250     Document Type: Article

References (58)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90
2. Chen, W. Q., Zhang, S. W., Zou, X. N., and Zhao, P. (2011) Cancer incidence and mortality in China. Chin. J. Cancer Res. 23, 3-9
3. Siegel, R., Naishadham, D., and Jemal, A. (2013) Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30
4. Yang, L., Parkin, D. M., Ferlay, J., Li, L., and Chen, Y. (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol. Biomarkers Prev. 14, 243-250
5. Kang, K. J., Kim, K. M., Min, B. H., Lee, J. H., and Kim, J. J. (2011) Endoscopic submucosal dissection of early gastric cancer. Gut Liver 5, 418-426
6. Emoto, S., Ishigami, H., Yamashita, H., Yamaguchi, H., Kaisaki, S., and Kitayama, J. (2012) Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer 15, 154-161
7. Li, Y., Yang, Y., Lu, M., and Shen, L. (2011) Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepatogastroenterology 58, 2166-2170
8. Ucar, E., Semerci, E., Ustun, H., Yetim, T., Huzmeli, C., and Gullu, M. (2008) Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv. Ther. 25, 1075-1084
9. Anderson, K. S., Wong, J., DSouza, G., Riemer, A. B., Lorch, J., Haddad, R., Pai, S. I., Longtine, J., McClean, M., LaBaer, J., Kelsey, K. T., and Posner, M. (2011) Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br. J. Cancer 104, 1896-1905
10. Burford, B., Gentry-Maharaj, A., Graham, R., Allen, D., Pedersen, J. W., Nudelman, A. S., Blixt, O., Fourkala, E. O., Bueti, D., Dawnay, A., Ford, J., Desai, R., David, L., Trinder, P., Acres, B., Schwientek, T., Gammerman, A., Reis, C. A., Silva, L., Osório, H., Hallett, R., Wandall, H. H., Mandel, U., Hollingsworth, M. A., Jacobs, I., Fentiman, I., Clausen, H., Taylor-Papadimitriou, J., Menon, U., and Burchell, J. M. (2013) Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. Br. J. Cancer 108, 2045-2055
11. Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G., and Snyder, M. (2007) Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. U.S.A. 104, 17494-17499
12. Wang, X., Yu, J., Sreekumar, A., Varambally, S., Shen, R., Giacherio, D., Mehra, R., Montie, J. E., Pienta, K. J., Sanda, M. G., Kantoff, P. W., Rubin, M. A., Wei, J. T., Ghosh, D., and Chinnaiyan, A. M. (2005) Autoantibody signatures in prostate cancer. N. Engl. J. Med. 353, 1224-1235
13. Chuang, H. Y., Ren, C. T., Chao, C. A., Wu, C. Y., Shivatare, S. S., Cheng, T. J., Wu, C. Y., and Wong, C. H. (2013) Synthesis and vaccine evaluation of the tumor-Associated carbohydrate antigen RM2 from prostate cancer. J. Am. Chem. Soc. 135, 11140-11150
14. Dorvillius, M., Garambois, V., Pourquier, D., Gutowski, M., Rouanet, P., Mani, J. C., Pugnière, M., Hynes, N. E., and Pèlegrin, A. (2002) Targeting of human breast cancer by a bispecific antibody directed against two tumour-Associated antigens: ErbB-2 and carcinoembryonic antigen. Tumour Biol. 23, 337-347
15. Jaramillo, A., Majumder, K., Manna, P. P., Fleming, T. P., Doherty, G., Dipersio, J. F., and Mohanakumar, T. (2002) Identification of HLA-A3-restricted CD8- T cell epitopes derived from mammaglobin-A, a tumorassociated antigen of human breast cancer. Int. J. Cancer 102, 499-506
16. Li, Y., Dong, X., Yin, Y., Su, Y., Xu, Q., Zhang, Y., Pang, X., Zhang, Y., and Chen, W. (2005) BJ-TSA-9, a novel human tumor-specific gene, has potential as a biomarker of lung cancer. Neoplasia 7, 1073-1080
17. Jeong, J. S., Jiang, L., Albino, E., Marrero, J., Rho, H. S., Hu, J., Hu, S., Vera, C., Bayron-Poueymiroy, D., Rivera-Pacheco, Z. A., Ramos, L., Torres-Castro, C., Qian, J., Bonaventura, J., Boeke, J. D., Yap, W. Y., Pino, I., Eichinger, D. J., Zhu, H., and Blackshaw, S. (2012) Rapid identification of monospecific monoclonal antibodies using a human proteome microarray. Mol. Cell. Proteomics 11, O111.016253
18. Ritchie, M. E., Silver, J., Oshlack, A., Holmes, M., Diyagama, D., Holloway, A., and Smyth, G. K. (2007) A comparison of background correction methods for two-colour microarrays. Bioinformatics 23, 2700-2707
19. Kauffmann, A., and Huber, W. (2010) Microarray data quality control improves the detection of differentially expressed genes. Genomics 95, 138-142
20. Bolstad, B. M., Irizarry, R. A., Astrand, M., and Speed, T. P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193
21. Chen, Y., Yang, L. N., Cheng, L., Tu, S., Guo, S. J., Le, H. Y., Xiong, Q., Mo, R., Li, C. Y., Jeong, J. S., Jiang, L., Blackshaw, S., Bi, L. J., Zhu, H., Tao, S. C., and Ge, F. (2013) Bcl2-Associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity. Mol. Cell. Proteomics 12, 2804-2819
22. Hao, Y., Yu, Y., Wang, L., Yan, M., Ji, J., Qu, Y., Zhang, J., Liu, B., and Zhu, Z. (2008) IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. J. Proteome Res. 7, 3668-3677
23. Jørgensen, J. T., and Hersom, M. (2012) HER2 as a prognostic marker in gastric cancer-A systematic analysis of data from the literature. J. Cancer 3, 137-144
24. Koskensalo, S., Mrena, J., Wiksten, J. P., Nordling, S., Kokkola, A., Hagstro m, J., and Haglund, C. (2010) MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol. 31, 149-155
25. Mrena, J., Wiksten, J. P., Kokkola, A., Nordling, S., Ristimäki, A., and Haglund, C. (2010) COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer. Tumour Biol. 31, 1-7
26. Tseng, C. W., Yang, J. C., Chen, C. N., Huang, H. C., Chuang, K. N., Lin, C. C., Lai, H. S., Lee, P. H., Chang, K. J., and Juan, H. F. (2011) Identification of 14-3-3 in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker. Proteomics 11, 2423-2439
27. Lee, J. W., Choi, H. S., Gyuris, J., Brent, R., and Moore, D. D. (1995) Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9, 243-254
28. Altincicek, B., Tenbaum, S. P., Dressel, U., Thormeyer, D., Renkawitz, R., and Baniahmad, A. (2000) Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J. Biol. Chem. 275, 7662-7667
29. Lykke-Andersen, K., Schaefer, L., Menon, S., Deng, X. W., Miller, J. B., and Wei, N. (2003) Disruption of the COP9 signalosome Csn2 subunit in mice causes deficient cell proliferation, accumulation of p53 and cyclin E, and early embryonic death. Mol. Cell. Biol. 23, 6790-6797
30. Vazquez-Ortiz, G., Pina-Sanchez, P., Vazquez, K., Duenas, A., Taja, L., Mendoza, P., Garcia, J. A., and Salcedo, M. (2005) Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer 5, 68
31. Wex, T., Levy, B., Wex, H., and Brömme, D. (2000) Human cathepsins W and F form a new subgroup of cathepsins that is evolutionary separated from the cathepsin B-And L-like cysteine proteases. Adv. Exp. Med. Biol. 477, 271-280
32. Santamaría, I., Velasco, G., Pendás, A. M., Paz, A., and López-Otín, C. (1999) Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J. Biol. Chem. 274, 13800-13809
33. Colgan, S. P., Eltzschig, H. K., Eckle, T., and Thompson, L. F. (2006) Physiological roles for ecto-5-nucleotidase (CD73). Purinergic Signal. 2, 351-360
34. Resta, R., Yamashita, Y., and Thompson, L. F. (1998) Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol. Rev. 161, 95-109
35. Yamashita, Y., Hooker, S. W., Jiang, H., Laurent, A. B., Resta, R., Khare, K., Coe, A., Kincade, P. W., and Thompson, L. F. (1998) CD73 expression and fyn-dependent signaling on murine lymphocytes. Eur. J. Immunol. 28, 2981-2990
36. Strohmeier, G. R., Lencer, W. I., Patapoff, T. W., Thompson, L. F., Carlson, S. L., Moe, S. J., Carnes, D. K., Mrsny, R. J., and Madara, J. L. (1997) Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J. Clin. Invest. 99, 2588-2601
37. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., DellAcqua, M. L., Rossini, P. M., Battistini, L., Rötzschke, O., and Falk, K. (2007) Expression of ectonucleotidase CD39 by Foxp3- Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225-1232
38. Dwyer, K. M., Deaglio, S., Gao, W., Friedman, D., Strom, T. B., and Robson, S. C. (2007) CD39 and control of cellular immune responses. Purinergic Signal. 3, 171-180
39. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F., Enjyoji, K., Linden, J., Oukka, M., Kuchroo, V. K., Strom, T. B., and Robson, S. C. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265
40. Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J., and Mosmann, T. R. (2006) T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5-Adenosine monophosphate to adenosine. J. Immunol. 177, 6780-6786
41. Canbolat, O., Durak, I., Cetin, R., Kavutcu, M., Demirci, S., and Oztürk, S. (1996) Activities of adenosine deaminase, 5-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Res. Treat. 37, 189-193
42. Eroglu, A., Canbolat, O., Demirci, S., Kocaoglu, H., Eryavuz, Y., and Akgül, H. (2000) Activities of adenosine deaminase and 5-nucleotidase in cancerous and noncancerous human colorectal tissues. Med. Oncol. 17, 319-324
43. Kondo, T., Nakazawa, T., Murata, S. I., and Katoh, R. (2006) Expression of CD73 and its ecto-5-nucleotidase activity are elevated in papillary thyroid carcinomas. Histopathology 48, 612-614
44. Sadej, R., Spychala, J., and Skladanowski, A. C. (2006) Ecto-5-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells. Nucleosides Nucleotides Nucleic Acids 25, 1119-1123
45. Saitoh, M., Nagai, K., Nakagawa, K., Yamamura, T., Yamamoto, S., and Nishizaki, T. (2004) Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMPactivated protein kinase. Biochem Pharmacol. 67, 2005-2011
46. Vannoni, D., Bernini, A., Carlucci, F., Civitelli, S., Di Pietro, M. C., Leoncini, R., Rosi, F., Tabucchi, A., Tanzini, G., and Marinello, E. (2004) Enzyme activities controlling adenosine levels in normal and neoplastic tissues. Med Oncol. 21, 187-195
47. Sadej, R., Spychala, J., and Skladanowski, A. C. (2006) Expression of ecto-5-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res. 16, 213-222
48. Wang, L., Zhou, X., Zhou, T., Ma, D., Chen, S., Zhi, X., Yin, L., Shao, Z., Ou, Z., and Zhou, P. (2008) Ecto-5-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J. Cancer Res. Clin. Oncol. 134, 365-372
49. Spychala, J., Lazarowski, E., Ostapkowicz, A., Ayscue, L. H., Jin, A., and Mitchell, B. S. (2004) Role of estrogen receptor in the regulation of ecto-5-nucleotidase and adenosine in breast cancer. Clin. Cancer Res. 10, 708-717
50. Salas, T. R., Petruseva, I., Lavrik, O., Bourdoncle, A., Mergny, J. L., Favre, A., and Saintomé, C. (2006) Human replication protein A unfolds telomeric G-quadruplexes. Nucleic Acids Res. 34, 4857-4865
51. de Lange, T. (2005) Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100-2110
52. dAdda di Fagagna, F., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N. P., and Jackson, S. P. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198
53. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352
54. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015
55. Shay, J. W., and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791
56. Allgayer, H., Babic, R., Gruetzner, K. U., Tarabichi, A., Schildberg, F. W., and Heiss, M. M. (2000) c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-Associated protease systems. J. Clin. Oncol. 18, 2201-2209
57. Chan, A. O., Chu, K. M., Lam, S. K., Wong, B. C., Kwok, K. F., Law, S., Ko, S., Hui, W. M., Yueng, Y. H., and Wong, J. (2003) Soluble E-cadherin is an independent pretherapeutic factor for long-Term survival in gastric cancer. J. Clin. Oncol. 21, 2288-2293
58. Jüttner, S., Wissmann, C., Jöns, T., Vieth, M., Hertel, J., Gretschel, S., Schlag, P. M., Kemmner, W., and Höcker, M. (2006) Vascular endothelial growth factor-D and its receptor VEGFR-3: Two novel independent prognostic markers in gastric adenocarcinoma. J. Clin. Oncol. 24, 228-240